Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | -0.4394 |
| December 31, 2025 | -0.6512 |
| September 30, 2025 | -1.236 |
| June 30, 2025 | -0.4176 |
| March 31, 2025 | -0.4206 |
| December 31, 2024 | -0.3999 |
| September 30, 2024 | -0.3816 |
| June 30, 2024 | -0.7049 |
| March 31, 2024 | -0.7391 |
| December 31, 2023 | -0.8205 |
| September 30, 2023 | -1.085 |
| June 30, 2023 | -1.697 |
| March 31, 2023 | -2.131 |
| December 31, 2022 | -4.988 |
| September 30, 2022 | 4.106 |
| June 30, 2022 | 1.065 |
| March 31, 2022 | 0.7232 |
| December 31, 2021 | 0.5611 |
| September 30, 2021 | 0.3691 |
| June 30, 2021 | 0.4729 |
| March 31, 2021 | 0.1556 |
| December 31, 2020 | 0.1385 |
| September 30, 2020 | 0.1344 |
| June 30, 2020 | 0.1595 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1442 |
| December 31, 2019 | 0.1232 |
| September 30, 2019 | 0.1219 |
| June 30, 2019 | 0.1192 |
| March 31, 2019 | 0.1577 |
| December 31, 2018 | 0.212 |
| September 30, 2018 | 0.2425 |
| June 30, 2018 | 0.231 |
| March 31, 2018 | 0.2311 |
| December 31, 2017 | 0.2065 |
| September 30, 2017 | 0.20 |
| June 30, 2017 | 0.4943 |
| March 31, 2017 | 0.8556 |
| December 31, 2016 | 0.6886 |
| September 30, 2016 | 0.6343 |
| June 30, 2016 | 0.5847 |
| March 31, 2016 | 0.7191 |
| December 31, 2015 | 0.6045 |
| September 30, 2015 | 0.5174 |
| June 30, 2015 | 0.4421 |
| March 31, 2015 | 0.6048 |
| December 31, 2014 | 0.4909 |
| September 30, 2014 | 1.395 |
| June 30, 2014 | 0.8654 |
| March 31, 2014 | 1.518 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Vericel Corp. | 0.2556 |
| Capricor Therapeutics, Inc. | 0.3698 |
| ARS Pharmaceuticals, Inc. | 7.727 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 101.08M |
| Total Liabilities (Quarterly) | 109.22M |
| Shareholders Equity (Quarterly) | -30.14M |
| Current Ratio | 2.687 |
| Net Debt Paydown Yield | 59.68% |